Bookmark?Remove?
Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial,…
(Reuters) – Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results for patients who received the highest dose. The news sent Eisai’s shares up as much as 14.6 percent in Fr... More »
